Remap Consulting is a specialist pharmaceutical pricing and market access consultancy
We work with people responsible for the pricing and reimbursement of products who are asking:
What is the optimal price for our product?
Have we got the right evidence to support pricing and market access at launch?
Do we have the right training capabilities in house to secure pricing and reimbursement?
What is the pricing and market access potential for our business development opportunities?
Launch
Implementation
Price & Market Access Training
Price
Optimization
We now offer the NICE META tool as part of our Launch service
Our mission is to support you in solving your pricing and market access challenges to improve patient access to your products
This has been an excellent two days. You have truly been a pleasure to work with, bringing great learning techniques as well as pricing and market access insights.
Excellent work. The project ran very smoothly and we appreciated your efficient approach to managing the project and delivery of final recommendations.
Latest News
National body to ensure CCG decisions for patient access to treatments are consistent
There needs to be a national body to examine CCG decisions ensuring that patient access to treatments is consistent across [...]
Remap team members to run Manchester 10k for East Cheshire Hospice
Some members of the Remap Consulting team will be running the Manchester 10k on the 19th May and are raising [...]
NICE approve Almirall’s Ilumetri, UCB’s Cimzia
The National Institute for Health and Care Excellence (NICE) has recommended Almirall's Ilumetri and UCB's Cimzia as treatment options for [...]
NICE suggests industry and payers need to do more to align on value, evidence and price
England’s cost effectiveness watchdog NICE can shift away from its current default of starting with a ‘no’ to new drugs, [...]